Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | APAF1 | O14727 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HK1 | P19367 | 1/20 | 0.32 |
| ▸ | GALK1 | P51570 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30019213 | 0.72 | ABCG2 (0.62) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL261676 | 0.72 | ABCG2 (0.62) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL725971 | 0.70 | ABCG2 (0.51) | ABCG2IDO1 | |
| SCHEMBL25254164 | 0.67 | — | — | |
| SCHEMBL4507290 | 0.67 | ABCG2 (0.37) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL4499072 | 0.66 | ABCG2 (0.46) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL1899426 | 0.66 | ABCG2 (0.40) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL4313632 | 0.66 | ABCG2 (0.40) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL28246158 | 0.66 | ABCG2 (0.40) | ABCG2IDO1KDM4EMEN1APAF1 | |
| SCHEMBL1820364 | 0.66 | ABCG2 (0.40) | ABCG2IDO1KDM4EMEN1APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4829498-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| US-7868197-B2 | Halogen substituted heteroatom-containing metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-01-11 | — | — | US | claimed |
| EP-1960442-A1 | HALOGEN SUBSTITUTED HETEROATOM-CONTAINING METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2008-08-27 | — | — | EP | claimed |
| WO-2007070046-A1 | HALOGEN SUBSTITUTED HETEROATOM-CONTAINING METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-06-21 | — | — | WO | claimed |
| US-20070135623-A1 | Halogen substituted heteroatom-containing metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | claimed |
| US-20070032619-A1 | Olefin polymerization methods | EQUISTAR CHEMICALS, LP | 2007-02-08 | — | — | US | claimed |
| JP-2006502252-A | — | — | 2006-01-19 | — | — | JP | claimed |
| EP-1525228-A2 | CATALYSTS AND PROCESS FOR MAKING POLYOLEFINS | Equistar Chemicals, LP (US) | 2005-04-27 | — | — | EP | claimed |
| EP-1497343-A1 | METHOD FOR POLYMERISATION OF OLEFINS WITH INDENO-INDOLYL CATALYSTS | Equistar Chemicals, LP (US) | 2005-01-19 | — | — | EP | claimed |
| US-6838410-B2 | Catalysts for making polyolefins | EQUISTAR CHEMICALS, LP (US) | 2005-01-04 | — | — | US | claimed |
| WO-2004013194-A2 | CATALYSTS AND PROCESS FOR MAKING POLYOLEFINS | EQUISTAR CHEMICALS, LP (US) | 2004-02-12 | — | — | WO | claimed |
| US-20040023791-A1 | Catalysts for making polyolefins | EQUISTAR CHEMICALS, LP | 2004-02-05 | — | — | US | claimed |
| WO-2003089485-A1 | METHOD FOR POLYMERISATION OF OLEFINS WITH INDENO-INDOLYL CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2003-10-30 | — | — | WO | claimed |
| US-20030195306-A1 | Method for making polyolefins | EQUISTAR CHEMICALS, LP | 2003-10-16 | — | — | US | claimed |
| US-11999763-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-06-04 | — | — | US | disclosed |
| US-20240124502-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-04-18 | — | — | US | disclosed |
| WO-2023187552-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2023-10-05 | — | — | WO | disclosed |
| US-20030229188-A1 | High-temperature solution process for polyolefin manufacture | EQUISTAR CHEMICALS, LP | 2003-12-11 | — | — | US | disclosed |
| WO-2003089485-A1 | METHOD FOR POLYMERISATION OF OLEFINS WITH INDENO-INDOLYL CATALYSTS | EQUISTAR CHEMICALS, LP (US) | 2003-10-30 | — | — | WO | disclosed |
| US-20030195306-A1 | Method for making polyolefins | EQUISTAR CHEMICALS, LP | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135623-A1 | Halogen substituted heteroatom-containing metallocene compounds for olefin polymerization | OPRM1, POLM, AP1M1 | ABCG2 3765/4885IDO1 3286/4885KDM4E 4141/4885 |
| US-20240124502-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | CYC1, CYP4F12, COASY | ABCG2 3872/4885IDO1 1631/4885KDM4E 4420/4885 |
| US-11999763-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | CYC1, CYP4F12, COASY | ABCG2 3872/4885IDO1 1631/4885KDM4E 4420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.